FDA NDC Directory · JSON-LD · Markdown

Ebanga

NDC 71655-578 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameAnsuvimab
Labeler / ManufacturerEmergent Manufacturing Operations Baltimore, LLC
Marketing categoryBiologic License Application · App BLA761172
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsANSUVIMAB (400 mg/8mL)
Marketing started20201221
Package count3

External sources

Source: openFDA. Public-domain (CC0).